JP Morgan Initiates Coverage On Seaport Therapeutics with Overweight Rating, Announces Price Target of $42
Benzinga Newsdesk 5 months ago
NewsPrice TargetInitiationAnalyst Ratings
JP Morgan analyst Tessa Romero initiates coverage on Seaport Therapeutics (NASDAQ:SPTX) with a Overweight rating and announces Price Target of $42.
JP Morgan analyst Tessa Romero initiates coverage on Seaport Therapeutics (NASDAQ:SPTX) with a Overweight rating and announces Price Target of $42.